(IFF) International Flavors - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4595061015

Flavors, Fragrances, Enzymes, Excipients

Specialty Chemicals
Market Cap in USD: 17,248m

IPO / Inception: 1981-12-31
12m vs SPY: -29.7%

EPS (Earnings per Share)

EPS CAGR: -53.55%
EPS Trend: -54.2%

Last SUE: -3.92
Qual. Beats: 0

Revenue

Rev. CAGR: -3.09%
Rev. Trend: -77.2%

Last SUE: 1.54
Qual. Beats: 2

Dividends

Dividend Yield	2.32%
Yield on Cost 5y	1.49%
Yield CAGR 5y	-15.38%
Payout Consistency	97.3%
Payout Ratio	36.6%

Risk via 5d forecast
Volatility	26.9%
Value at Risk 5%th	40.4%
Relative Tail Risk	-8.89%

Reward TTM
Sharpe Ratio	-0.53
Alpha	-29.49
CAGR/Max DD	-0.30

Character TTM
Hurst Exponent	0.489
Beta	0.727
Beta Downside	0.486

Drawdowns 3y
Max DD	45.07%
Mean DD	26.65%
Median DD	28.09%

Description: IFF International Flavors January 02, 2026

International Flavors & Fragrances Inc. (NYSE:IFF) is a global specialty-chemicals company that develops and sells ingredients for food, beverage, health & biosciences, fragrance, and pharmaceutical markets. Its operations are organized into four reporting segments: Nourish (natural-based food ingredients and flavors), Health & Biosciences (enzymes, cultures, animal nutrition, and grain-processing solutions), Scent (fragrance compounds and ingredients), and Pharma Solutions (cellulosic and seaweed-derived excipients). The firm, founded in 1909, is headquartered in New York and serves customers across the United States, Europe, and the rest of the world.

In FY 2023 IFF reported revenue of roughly $11.6 billion, a 4 % year-over-year increase driven primarily by the Nourish segment’s plant-based protein portfolio and the Scent segment’s premium fragrance demand. Adjusted EBITDA margin held steady near 13 %, while free cash flow conversion remained above 80 %, reflecting strong pricing power and efficient capital allocation. The company’s balance sheet is solid, with net debt-to-EBITDA ≈ 1.2×, indicating low financial risk.

Key economic and sector drivers for IFF include: (1) the accelerating consumer shift toward clean-label, plant-based, and functional foods, which fuels demand for soy, pea protein, natural sweeteners, and antimicrobial ingredients; (2) rising global fragrance spending, especially in emerging markets where premium personal-care products are gaining market share; and (3) regulatory pressure on synthetic additives, prompting manufacturers to source natural alternatives-a trend that aligns with IFF’s R&D pipeline and sustainability commitments.

For a deeper dive into IFF’s valuation metrics and scenario analysis, you may find ValueRay’s research platform useful.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (-412.0m TTM) > 0 and > 6% of Revenue (6% = 664.3m TTM)

FCFTA 0.01 (>2.0%) and ΔFCFTA -1.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 16.32% (prev 45.59%; Δ -29.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.03 (>3.0%) and CFO 900.0m > Net Income -412.0m (YES >=105%, WARN >=100%)

Net Debt (6.52b) to EBITDA (698.0m) ratio: 9.35 <= 3.0 (WARN <= 3.5)

Current Ratio 1.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (257.0m) change vs 12m ago 0.0% (target <= -2.0% for YES)

Gross Margin 36.38% (prev 35.07%; Δ 1.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 39.76% (prev 38.14%; Δ 1.61pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -1.08 (EBITDA TTM 698.0m / Interest Expense TTM 249.0m) >= 6 (WARN >= 3)

Altman Z'' -0.46

(A) 0.07 = (Total Current Assets 5.88b - Total Current Liabilities 4.07b) / Total Assets 25.77b

(B) -0.13 = Retained Earnings (Balance) -3.35b / Total Assets 25.77b

(D) -0.42 = Book Value of Equity -4.77b / Total Liabilities 11.49b

Total Rating: -0.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 32.91

1. Piotroski 4.50pt

2. FCF Yield 1.40%

3. FCF Margin 3.00%

4. Debt/Equity 0.50

5. Debt/Ebitda 9.35

6. ROIC - WACC (= -7.14)%

7. RoE -2.96%

8. Rev. Trend -77.22%

9. EPS Trend -54.19%

What is the price of IFF shares?

As of January 13, 2026, the stock is trading at USD 69.10 with a total of 1,376,388 shares traded.
Over the past week, the price has changed by +3.20%, over one month by +9.92%, over three months by +15.68% and over the past year by -15.10%.

Is IFF a buy, sell or hold?

International Flavors has received a consensus analysts rating of 4.14. Therefore, it is recommended to buy IFF.

Strong Buy: 10
Buy: 7
Hold: 4
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the IFF price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	81.5	17.9%
Analysts Target Price	81.5	17.9%
ValueRay Target Price	68.2	-1.3%

IFF Fundamental Data Overview January 09, 2026

P/E Forward = 15.6006
P/S = 1.5578
P/B = 1.2385
P/EG = 2.3546
Beta = 1.056
Revenue TTM = 11.07b USD
EBIT TTM = -270.0m USD
EBITDA TTM = 698.0m USD
Long Term Debt = 4.74b USD (from longTermDebt, last quarter)
Short Term Debt = 1.31b USD (from shortTermDebt, last quarter)
Debt = 7.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.52b USD (from netDebt column, last quarter)
Enterprise Value = 23.77b USD (17.25b + Debt 7.14b - CCE 621.0m)
Interest Coverage Ratio = -1.08 (Ebit TTM -270.0m / Interest Expense TTM 249.0m)
EV/FCF = 71.60x (Enterprise Value 23.77b / FCF TTM 332.0m)
FCF Yield = 1.40% (FCF TTM 332.0m / Enterprise Value 23.77b)
FCF Margin = 3.00% (FCF TTM 332.0m / Revenue TTM 11.07b)
Net Margin = -3.72% (Net Income TTM -412.0m / Revenue TTM 11.07b)
Gross Margin = 36.38% ((Revenue TTM 11.07b - Cost of Revenue TTM 7.04b) / Revenue TTM)
Gross Margin QoQ = 36.49% (prev 37.26%)
Tobins Q-Ratio = 0.92 (Enterprise Value 23.77b / Total Assets 25.77b)
Interest Expense / Debt = 0.67% (Interest Expense 48.0m / Debt 7.14b)
Taxrate = 26.79% (15.0m / 56.0m)
NOPAT = -197.7m (EBIT -270.0m * (1 - 26.79%)) [loss with tax shield]
Current Ratio = 1.44 (Total Current Assets 5.88b / Total Current Liabilities 4.07b)
Debt / Equity = 0.50 (Debt 7.14b / totalStockholderEquity, last quarter 14.24b)
Debt / EBITDA = 9.35 (Net Debt 6.52b / EBITDA 698.0m)
Debt / FCF = 19.65 (Net Debt 6.52b / FCF TTM 332.0m)
Total Stockholder Equity = 13.92b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.48% (Net Income -412.0m / Total Assets 25.77b)
RoE = -2.96% (Net Income TTM -412.0m / Total Stockholder Equity 13.92b)
RoCE = -1.45% (EBIT -270.0m / Capital Employed (Equity 13.92b + L.T.Debt 4.74b))
RoIC = -0.92% (negative operating profit) (NOPAT -197.7m / Invested Capital 21.55b)
WACC = 6.22% (E(17.25b)/V(24.39b) * Re(8.59%) + D(7.14b)/V(24.39b) * Rd(0.67%) * (1-Tc(0.27)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.39%
[DCF Debug] Terminal Value 79.09% ; FCFF base≈569.2m ; Y1≈373.6m ; Y5≈170.5m
Fair Price DCF = N/A (negative equity: EV 4.94b - Net Debt 6.52b = -1.58b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -54.19 | EPS CAGR: -53.55% | SUE: -3.92 | # QB: 0
Revenue Correlation: -77.22 | Revenue CAGR: -3.09% | SUE: 1.54 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.15 | Chg30d=+0.001 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=4.47 | Chg30d=-0.026 | Revisions Net=-2 | Growth EPS=+4.9% | Growth Revenue=-2.0%

Additional Sources for IFF Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle